持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2011/11/18 | 日証協 | 285,091株 | +22.31% | 117,910株 | +24.29% | 461,972株 | +15.5% | 394,000株 | +248.06% |
2011/11/11 | 日証協 | 233,091株 | +18.22% | 94,865株 | -33.09% | 399,972株 | -8.48% | 113,200株 | -26.3% |
2011/11/04 | 日証協 | 197,165株 | -5.3% | 141,784株 | +94.34% | 437,046株 | -5.01% | 153,600株 | -13.02% |
2011/10/28 | 日証協 | 208,200株 | +8.1% | 72,955株 | +63.37% | 460,081株 | -4.13% | 176,600株 | +72.29% |
2011/10/21 | 日証協 | 192,600株 | +17.8% | 44,655株 | -27.47% | 479,881株 | +2.59% | 102,500株 | +26.86% |
2011/10/14 | 日証協 | 163,500株 | +8.72% | 61,565株 | -16.48% | 467,781株 | +15.54% | 80,800株 | -25.32% |
2011/10/07 | 日証協 | 150,391株 | +7.81% | 73,710株 | -45.28% | 404,872株 | +79.26% | 108,201株 | -22.28% |
2011/09/30 | 日証協 | 139,500株 | -12.04% | 134,711株 | +226.45% | 225,860株 | -41.78% | 139,211株 | +49.05% |
2011/09/22 | 日証協 | 158,600株 | +0.83% | 41,265株 | -56.46% | 387,972株 | +8.17% | 93,400株 | -58.89% |
2011/09/16 | 日証協 | 157,300株 | -1.56% | 94,765株 | +59.9% | 358,672株 | -2.05% | 227,200株 | +99.76% |
2011/09/09 | 日証協 | 159,800株 | +10.41% | 59,265株 | -44.3% | 366,172株 | +8.97% | 113,736株 | +17.25% |
2011/09/02 | 日証協 | 144,736株 | -6.17% | 106,400株 | +324.67% | 336,017株 | -13.38% | 97,000株 | +62.63% |
2011/08/26 | 日証協 | 154,256株 | +6.6% | 25,055株 | 0% | 387,937株 | +4.99% | 59,645株 | -31.44% |
2011/08/19 | 日証協 | 144,711株 | -0.69% | 0株 | -100% | 369,491株 | -4.54% | 87,000株 | -56.59% |
2011/08/12 | 日証協 | 145,711株 | -18.65% | 7,755株 | -73.18% | 387,078株 | +65.64% | 200,398株 | +77.34% |
2011/08/05 | 日証協 | 179,111株 | +4.31% | 28,910株 | -75.91% | 233,692株 | -26.21% | 113,000株 | +82.26% |
2011/07/29 | 日証協 | 171,711株 | -1.72% | 120,000株 | +400% | 316,692株 | +0.64% | 62,000株 | +376.92% |
2011/07/22 | 日証協 | 174,711株 | +0.58% | 24,000株 | -35.14% | 314,692株 | +0.96% | 13,000株 | +18.18% |
2011/07/15 | 日証協 | 173,711株 | +1.16% | 37,000株 | +37.04% | 311,692株 | -3.41% | 11,000株 | -52.17% |
※株式分割は考慮していませんのでご注意ください。
Page Top